)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
DBV Technologies
DBV Technologies (DBV) investor relations material
DBV Technologies Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary4 May, 2026
Mission and company overview
Focused on developing novel treatments for pediatric food allergy, especially peanut allergy, using epicutaneous immunotherapy (EPIT) via the VIASKIN patch technology.
Over 1.1 million patches administered to more than 1,600 children aged 1-7 years.
Science-driven leadership with deep regulatory and commercial experience.
Product pipeline and clinical milestones
VIASKIN Peanut patch is the lead product, targeting children aged 1-3 and 4-7 years.
VITESSE Phase 3 study in 4-7 year-olds met primary endpoint; BLA submission anticipated in 1H 2026, eligible for priority review.
EPITOPE Phase 3 study in 1-3 year-olds met primary endpoint; BLA submission anticipated in 2H 2026 under Accelerated Approval pathway.
EMA guidance supports MAA submission for 1-7 year-olds in Europe, requiring three studies including new safety data.
Market opportunity and dynamics
Approximately 670,000 children aged 1-7 in the US and 615,000 in the EU have peanut allergy.
Annual economic impact of peanut allergy in the US is $33B, with significant quality of life burden.
Current treatments (oral immunotherapy, omalizumab) have limitations; 90% of allergists see need for new options.
VIASKIN Peanut patch offers at-home, non-invasive, daily application with no oral ingestion or injections.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from DBV Technologies
- Cash reserves up to $229M; net loss widens as launch and regulatory prep for VIASKIN advance.DBV
Q1 202630 Apr 2026 - Advanced VIASKIN Peanut Patch programs and secured funding support cash runway into Q2 2027.DBVQ4 202527 Mar 2026
- Peanut allergy patch therapy nears launch with strong data, targeting young children and future pipeline growth.DBVThe Citizens Life Sciences Conference 202610 Mar 2026
- Viaskin Peanut advances toward 2026 BLAs and 2027 launch, backed by robust clinical data.DBVGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
- Patch-based immunotherapy for pediatric peanut allergy advances toward US and EU approval.DBVCorporate presentation12 Feb 2026
- Net loss hit $60.5M in H1 2024; pivotal trials advance and cash runway extends into Q1 2025.DBVQ2 20242 Feb 2026
- Viaskin Peanut patch advances toward late 2025 BLA filings, backed by strong efficacy and safety.DBVGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Skin-based peanut allergy therapy for children nears key FDA and clinical milestones.DBVH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Accelerated approval pathway advances, but funding is needed as key studies begin.DBVStatus Update19 Jan 2026
Next DBV Technologies earnings date
Q2 202629 Jul, 2026
DBV Technologies
Next DBV Technologies earnings date
Q2 202629 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage